Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2020

09.11.2019 | Original Article

Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation

verfasst von: Sasha Deutsch-Link, Robert M. Weinrieb, Lauren S. Jones, Steven F. Solga, Ethan M. Weinberg, Marina Serper

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Alcohol-related liver disease (ALD) is the leading indication for liver transplantation (LT) in the USA. Alcohol relapse post-LT can negatively impact long-term outcomes, and prognostic scoring systems are available for further study.

Aims

Our study aims were to: (1) evaluate the relationship between alcohol relapse and rejection and mortality, (2) investigate risk factors for relapse, and (3) assess predictive validity of the SIPAT (Stanford Integrated Psychosocial Assessment for Transplant) and SALT (Sustained Alcohol Use Post-Liver Transplant) scores on post-LT alcohol relapse.

Methods

We conducted a retrospective chart review of 155 patients transplanted for chronic ALD at a single transplant center. Cox proportional hazard models assessed the relationship between alcohol relapse and allograft rejection and psychosocial risk factors for relapse.

Results

20% of patients met criteria for alcohol relapse. Alcohol relapse was associated with allograft rejection (HR 2.33, 95% CI 1.11–4.91, p = .03). Three variables most strongly associated with alcohol relapse: prior relapse, failure to engage in recommended alcohol treatment, and continued drinking with liver disease, which were combined into a psychosocial model. SIPAT score≥ 21 and SALT score ≥ 7 were associated with alcohol relapse (HR 6.40, 95% CI 1.36–30.18, p = .019 and HR 2.30, 95% CI 1.12–4.75, p = .024). Receiver operator characteristic analysis compared predictive ability of our psychosocial model to SIPAT (C-statistic .83 compared to .71) and SALT (C-statistic = .77 compared to .62).

Conclusion

We identified important psychosocial predictors of post-LT alcohol relapse and validated SIPAT and SALT scores as pre-transplant risk factors for alcohol relapse.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kim WR, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: liver. Am J Transpl. 2014;14:69–96.CrossRef Kim WR, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: liver. Am J Transpl. 2014;14:69–96.CrossRef
2.
Zurück zum Zitat Augusto Marroni C, de Medeiros Fleck JA, Alves Fernandes S, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24:2785–2805.CrossRef Augusto Marroni C, de Medeiros Fleck JA, Alves Fernandes S, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24:2785–2805.CrossRef
3.
Zurück zum Zitat Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the united states. Clin Gastroenterol Hepatol. 2018;16:1356–1358.PubMedCrossRef Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the united states. Clin Gastroenterol Hepatol. 2018;16:1356–1358.PubMedCrossRef
4.
Zurück zum Zitat Kling CE, Perkins JD, Sibulesky L, Carithers RL, Donovan DM. Recent trends in liver transplantation for alcoholic liver disease in the United States Retrospective Cohort Study. World J Hepatol. 2017;9:1315–1321.PubMedPubMedCentralCrossRef Kling CE, Perkins JD, Sibulesky L, Carithers RL, Donovan DM. Recent trends in liver transplantation for alcoholic liver disease in the United States Retrospective Cohort Study. World J Hepatol. 2017;9:1315–1321.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Han BH, Moore AA, Sherman S, Keyes KM, Palamar JJ. Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005–2014. Drug Alcohol Depend. 2017;170:198–207.PubMedCrossRef Han BH, Moore AA, Sherman S, Keyes KM, Palamar JJ. Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005–2014. Drug Alcohol Depend. 2017;170:198–207.PubMedCrossRef
6.
Zurück zum Zitat Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001–2016. JAMA. 2019;321:1723–1725.PubMedPubMedCentralCrossRef Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of alcoholic fatty liver disease among adults in the United States, 2001–2016. JAMA. 2019;321:1723–1725.PubMedPubMedCentralCrossRef
7.
8.
Zurück zum Zitat De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med. 2007;167:1183–1188.CrossRefPubMed De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med. 2007;167:1183–1188.CrossRefPubMed
9.
Zurück zum Zitat Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transplant. 2007;13:197–205.CrossRef Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transplant. 2007;13:197–205.CrossRef
10.
Zurück zum Zitat Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol. 2003;38:629–634.CrossRefPubMed Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol. 2003;38:629–634.CrossRefPubMed
11.
12.
Zurück zum Zitat Moss AHSM. Should alcoholics compete equally for transplantation? JAMA. 1992;265:1295–1298.CrossRef Moss AHSM. Should alcoholics compete equally for transplantation? JAMA. 1992;265:1295–1298.CrossRef
13.
Zurück zum Zitat Ubel PA. Transplantation in alcoholics: separating prognosis and responsibility from social biases. Liver Transplant Surg. 1997;3:343–346.CrossRef Ubel PA. Transplantation in alcoholics: separating prognosis and responsibility from social biases. Liver Transplant Surg. 1997;3:343–346.CrossRef
14.
Zurück zum Zitat Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929–937.PubMedCrossRef Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929–937.PubMedCrossRef
15.
Zurück zum Zitat Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern Med. 2019;179:340.PubMedPubMedCentralCrossRef Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern Med. 2019;179:340.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.PubMedPubMedCentralCrossRef Dew MA, DiMartini AF, Steel J, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14:159–172.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Karim Z, Intaraprasong P, Scudamore CH, et al. Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol Hepatol. 2010;24:245–250. Karim Z, Intaraprasong P, Scudamore CH, et al. Predictors of relapse to significant alcohol drinking after liver transplantation. Can J Gastroenterol Hepatol. 2010;24:245–250.
18.
Zurück zum Zitat Maldonado J. SIPAT update: assessment of the performance of the Stanford Integrated Psychosocial Assessment for Transplantation during the post-transplant period. J Psychosom Res. 2016;85:73.CrossRef Maldonado J. SIPAT update: assessment of the performance of the Stanford Integrated Psychosocial Assessment for Transplantation during the post-transplant period. J Psychosom Res. 2016;85:73.CrossRef
19.
Zurück zum Zitat Lee BP, Vittinghoff E, Hsu C, et al. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score. Hepatology. 2019;69:1477–1487.PubMedPubMedCentralCrossRef Lee BP, Vittinghoff E, Hsu C, et al. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver transplant score. Hepatology. 2019;69:1477–1487.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Thursz M, Gual A, Lackner C, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69:154–181.CrossRef Thursz M, Gual A, Lackner C, et al. EASL clinical practice guidelines: management of alcohol-related liver disease. J Hepatol. 2018;69:154–181.CrossRef
21.
Zurück zum Zitat Tandon P, Reddy KR, O’Leary JG, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017;65:217–224.PubMedCrossRef Tandon P, Reddy KR, O’Leary JG, et al. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017;65:217–224.PubMedCrossRef
22.
Zurück zum Zitat Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transplant Surg. 1999;5:318–331.CrossRef Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transplant Surg. 1999;5:318–331.CrossRef
23.
Zurück zum Zitat Pizzo HP, Ettenger RB, Gjertson DW, et al. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. Pediatr Nephrol. 2016;31:2345–2352.PubMedCrossRef Pizzo HP, Ettenger RB, Gjertson DW, et al. Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. Pediatr Nephrol. 2016;31:2345–2352.PubMedCrossRef
24.
Zurück zum Zitat Del BA, Congy-Jolivet N, Danjoux M, et al. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol. 2018;24:1795–1802.CrossRef Del BA, Congy-Jolivet N, Danjoux M, et al. High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation. World J Gastroenterol. 2018;24:1795–1802.CrossRef
25.
Zurück zum Zitat Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–132.PubMedCrossRef Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123–132.PubMedCrossRef
26.
Zurück zum Zitat Lee BP, Mehta N, Platt L, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology. 2018;155:e1. Lee BP, Mehta N, Platt L, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology. 2018;155:e1.
27.
Zurück zum Zitat Maldonado JR, Sher Y, Lolak S, et al. The Stanford Integrated Psychosocial Assessment for Transplantation. Psychosom Med. 2015;77:1018–1030.PubMedCrossRef Maldonado JR, Sher Y, Lolak S, et al. The Stanford Integrated Psychosocial Assessment for Transplantation. Psychosom Med. 2015;77:1018–1030.PubMedCrossRef
28.
Zurück zum Zitat Kodali S, Kaif M, Tariq R, Singal AK. Alcohol relapse after liver transplantation for alcoholic cirrhosis—impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53:166–172.PubMedCrossRef Kodali S, Kaif M, Tariq R, Singal AK. Alcohol relapse after liver transplantation for alcoholic cirrhosis—impact on liver graft and patient survival: a meta-analysis. Alcohol Alcohol. 2018;53:166–172.PubMedCrossRef
29.
Zurück zum Zitat Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transplant. 2004;10:S31–S38.CrossRef Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transplant. 2004;10:S31–S38.CrossRef
30.
Zurück zum Zitat Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transplant. 2001;7:418–427.CrossRef Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transplant. 2001;7:418–427.CrossRef
31.
Zurück zum Zitat DiMartini A, Weinrieb R, Fireman M. Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am. 2002;25:195–209.PubMedCrossRef DiMartini A, Weinrieb R, Fireman M. Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am. 2002;25:195–209.PubMedCrossRef
32.
33.
Zurück zum Zitat Voigt M. Abstract 0247. Liver Meet; 2018. Voigt M. Abstract 0247. Liver Meet; 2018.
34.
Zurück zum Zitat O’Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67:2367–2374.PubMedCrossRef O’Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67:2367–2374.PubMedCrossRef
35.
Zurück zum Zitat Sacco P, Sultan S, Tuten M, et al. Substance use and psychosocial functioning in a sample of liver transplant recipients with alcohol-related liver disease. Transplant Proc. 2018;50:3689–3693.PubMedCrossRef Sacco P, Sultan S, Tuten M, et al. Substance use and psychosocial functioning in a sample of liver transplant recipients with alcohol-related liver disease. Transplant Proc. 2018;50:3689–3693.PubMedCrossRef
36.
Zurück zum Zitat Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology. 2011;54:1640–1649.PubMedCrossRef Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology. 2011;54:1640–1649.PubMedCrossRef
37.
Zurück zum Zitat Weinrieb RM, Van Horn DHA, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transplant. 2011;17:539–547.CrossRef Weinrieb RM, Van Horn DHA, Lynch KG, Lucey MR. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transplant. 2011;17:539–547.CrossRef
38.
Zurück zum Zitat Addolorato G, Mirijello A, Leggio L, et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res. 2013;37:1601–1608.PubMedPubMedCentralCrossRef Addolorato G, Mirijello A, Leggio L, et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res. 2013;37:1601–1608.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Weinrieb RM, Van Horn DHA, Mclellan AT, et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics. 2001;42:110–116.PubMedCrossRef Weinrieb RM, Van Horn DHA, Mclellan AT, et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics. 2001;42:110–116.PubMedCrossRef
40.
Zurück zum Zitat Georgiou G. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transplant. 2003;9:772–775.CrossRef Georgiou G. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transplant. 2003;9:772–775.CrossRef
41.
Zurück zum Zitat Peeraphatdit TB, Kamath PS, Karpyak VM, et al. Alcohol rehabilitation within 30 days of hospital discharge is associated with reduced readmission, relapse, and death in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2019;pii:S1542-3565. Peeraphatdit TB, Kamath PS, Karpyak VM, et al. Alcohol rehabilitation within 30 days of hospital discharge is associated with reduced readmission, relapse, and death in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2019;pii:S1542-3565.
42.
Zurück zum Zitat Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922.PubMedCrossRef Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922.PubMedCrossRef
43.
Zurück zum Zitat Leggio L, Lee MR. Treatment of alcohol use disorder in patients with alcoholic liver disease. Am J Med. 2017;130:124–134.PubMedCrossRef Leggio L, Lee MR. Treatment of alcohol use disorder in patients with alcoholic liver disease. Am J Med. 2017;130:124–134.PubMedCrossRef
44.
Zurück zum Zitat Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014;38:2169–2177.PubMedPubMedCentralCrossRef Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014;38:2169–2177.PubMedPubMedCentralCrossRef
Metadaten
Titel
Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation
verfasst von
Sasha Deutsch-Link
Robert M. Weinrieb
Lauren S. Jones
Steven F. Solga
Ethan M. Weinberg
Marina Serper
Publikationsdatum
09.11.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05937-4

Weitere Artikel der Ausgabe 7/2020

Digestive Diseases and Sciences 7/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.